Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,487 | -23,418 | -73,671 | -89,194 | -66,060 |
| Depreciation Amortization | 100 | 139 | 1,227 | 963 | 642 |
| Accounts receivable | 34,084 | -1,636 | -393 | 33,542 | 33,823 |
| Other Working Capital | 41,328 | 717 | 4,005 | 38,363 | 72,319 |
| Other Operating Activity | -29,359 | 3,868 | 12,673 | -23,455 | -25,888 |
| Operating Cash Flow | $-11,334 | $-20,330 | $-56,159 | $-39,781 | $14,836 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 122,803 | 56,330 | 149,998 | 97,868 | 54,118 |
| PPE Investments | -469 | -296 | -1,622 | -1,172 | -575 |
| Purchase Of Investment | -121,466 | -48,599 | -330,636 | -265,648 | -177,536 |
| Sale Of Investment | 7,998 | 4,999 | 5,000 | 0 | 0 |
| Investing Cash Flow | $8,866 | $12,434 | $-177,260 | $-168,952 | $-123,993 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6 | -1 | -5 | -4 | -3 |
| Common Stock Issued | 96,129 | 95,912 | 116,245 | 111,001 | 47,215 |
| Financing Cash Flow | $96,123 | $95,911 | $116,240 | $110,997 | $47,212 |
| Beginning Cash Position | 71,437 | 71,437 | 188,616 | 188,616 | 188,616 |
| End Cash Position | 165,092 | 159,452 | 71,437 | 90,880 | 126,671 |
| Net Cash Flow | $93,655 | $88,015 | $-117,179 | $-97,736 | $-61,945 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,334 | -20,330 | -56,159 | -39,781 | 14,836 |
| Capital Expenditure | -469 | -296 | -1,622 | -1,172 | -575 |
| Free Cash Flow | -11,803 | -20,626 | -57,781 | -40,953 | 14,261 |